Ingredient
Phenyl Salicylate
Phenyl Salicylate is flagged for pregnancy, trying to conceive, breastfeeding and PCOS. The concern behind the strongest flag is hormone disruptor and absorbed into the body.
- Salol
- Phenol Salicylate
- 2-Hydroxybenzoic Acid Phenyl Ester
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Phenyl Salicylate and pregnancy
Not Recommended
- Hormone disruptor
- Absorbed into the body
Phenyl Salicylate is a salicylic acid derivative used for UV protection and as an antimicrobial agent in cosmetics. Like other salicylates, it can be absorbed through the skin and metabolized into salicylic acid. According to ECHA assessments, phenyl salicylate has demonstrated potential endocrine-disrupting activity in laboratory studies, raising concerns about hormonal interference during pregnancy. While topical salicylic acid at low concentrations is often considered acceptable during pregnancy, phenyl salicylate's specific hormonal effects and its conversion to salicylic acid create a compounded concern. The ingredient's ability to penetrate skin and its potential effects on thyroid hormones are particularly relevant during fetal development. Most dermatologists and obstetricians recommend avoiding salicylate derivatives with endocrine-disrupting potential during pregnancy as a precautionary measure. While direct human pregnancy data is limited, the combination of hormonal concerns and salicylate metabolism leads medical professionals to suggest safer alternatives.
Phenyl Salicylate and breastfeeding
Caution Advised
- Passes into breast milk
- Hormone disruptor
Phenyl Salicylate is metabolized into salicylic acid in the body, which can pass into breast milk. While topical absorption is lower than oral intake, the ingredient's endocrine-disrupting properties raise additional concerns during breastfeeding. Salicylates can transfer to breast milk, and while topical use generally results in minimal transfer, phenyl salicylate's potential hormonal effects add complexity. The AAD notes that salicylates should be used cautiously during breastfeeding, particularly in leave-on products or over large body areas. The ingredient's thyroid-interfering properties could theoretically affect infant development, though specific breastfeeding studies are lacking. Many healthcare providers suggest limiting exposure to endocrine-disrupting compounds during breastfeeding. While not an absolute contraindication, the combination of salicylate metabolism and hormonal concerns leads to a recommendation for caution or avoidance, especially in products applied to large areas or the breast region.
Phenyl Salicylate and postpartum
Safe to Use
For postpartum women who are not breastfeeding, phenyl salicylate presents minimal reproductive concerns. The primary considerations are the same as for the general population—potential skin sensitivity and the ingredient's endocrine-disrupting properties at a systemic level. While the endocrine concerns remain theoretically relevant, the absence of pregnancy or breastfeeding reduces the immediate risk to vulnerable populations. Standard cosmetic use in regulated concentrations is generally considered acceptable, though individuals with thyroid conditions or hormone sensitivity may want to exercise caution.
Phenyl Salicylate and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
Phenyl Salicylate's potential endocrine-disrupting properties are particularly relevant for women trying to conceive. Hormonal balance is critical for ovulation, conception, and early pregnancy, and exposure to compounds that may interfere with thyroid or reproductive hormones is generally discouraged. Reproductive endocrinologists recommend minimizing exposure to endocrine disruptors during the preconception period, as hormonal disruption can affect fertility and early embryonic development. While specific fertility studies on phenyl salicylate are limited, its documented potential for thyroid interference and the precautionary principle applied to TTC populations suggest avoiding this ingredient in favor of alternatives without hormonal concerns.
Phenyl Salicylate and PCOS
Caution Advised
- Interferes with hormones
- Endocrine disruptor
Phenyl Salicylate has antimicrobial and mild anti-inflammatory properties that could theoretically benefit PCOS-related acne. However, its classification as a potential endocrine disruptor creates concerns for women with hormonal imbalances. PCOS is characterized by hormonal dysregulation, particularly involving androgens and insulin sensitivity. According to ECHA evaluations, phenyl salicylate may interfere with thyroid hormone function, which is already a concern for some women with PCOS. Adding an ingredient with endocrine-disrupting potential could theoretically complicate hormone management, though direct studies linking phenyl salicylate to PCOS symptom exacerbation are lacking. Endocrinologists and dermatologists treating PCOS often recommend minimizing exposure to known endocrine disruptors when possible. While the ingredient's antimicrobial benefits might help with acne, safer alternatives without hormonal interference potential are typically preferred for women actively managing PCOS.
Phenyl Salicylate and general use
Safe to Use
- Common allergen
- Endocrine disruptor
For the general population, phenyl salicylate is permitted in cosmetics under EU regulations with concentration restrictions. It functions as a UV absorber, antimicrobial agent, and fragrance component. The ingredient has a long history of use in personal care products. The primary concerns for general use are potential skin sensitization and the ingredient's classification as a suspected endocrine disruptor. ECHA has identified phenyl salicylate for further evaluation regarding hormonal effects. Some individuals may experience allergic contact dermatitis, though this is relatively uncommon at cosmetic concentrations. The EU Cosmetics Regulation restricts phenyl salicylate to 0.5% when used as a UV filter, reflecting regulatory acknowledgment of its safety profile at controlled concentrations. For most adults without specific hormonal concerns, the ingredient is considered acceptable in properly formulated cosmetics, though individuals with thyroid conditions or hormone-sensitive conditions may prefer alternatives.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Phenyl Salicylate, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store